Skip to Main Content

Paper Details

Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility gene.
Oncotarget
42
2017
517 genes, APEX1, APLF, ATX, Cancer, DNA repair genes, EME1, EOC, FANCL, FANCM, FANCM mutations, HGSOC, MAD2L2, PARP2, PARP3, POLN, RAD54L, SMUG1, epithelial ovarian cancer, genes, germline DNA, high grade serous ovarian cancer, high-grade serous ovarian cancer, susceptibility gene
Author NameAffiliation
Honglin SongUniversity of Cambridge
Susan J RamusUniversity of New South Wales
Susan J RamusThe Kinghorn Cancer Centre, Garvan Institute of Medical Research
Susan J RamusUniversity of New South Wales
Susan J RamusThe Kinghorn Cancer Centre, Garvan Institute of Medical Research
Jonathan TyrerUniversity of Cambridge
Maria P IntermaggioUniversity of New South Wales
Maria P IntermaggioUniversity of New South Wales
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellOvarian Cancer Action Research Centre, Imperial College London
David D L BowtellUniversity of Melbourne
David D L BowtellUniversity of Melbourne
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellOvarian Cancer Action Research Centre, Imperial College London
David D L BowtellUniversity of Melbourne
David D L BowtellUniversity of Melbourne
Aocs GroupPeter MacCallum Cancer Centre
Aocs GroupThe QIMR Berghofer Medical Research Institute
Aocs GroupWestmead Millennium Institute, Westmead Hospital
Mine S CicekMayo Clinic
Brooke L FridleyUniversity of Kansas Medical Center
Jennifer AlsopUniversity of Cambridge
Mercedes Jimenez-LinanAddenbrooke's Hospital
Anna M PiskorzCancer Research UK Cambridge Institute, University of Cambridge
Teodora GoranovaCancer Research UK Cambridge Institute, University of Cambridge
Lara E Sucheston-CampbellRoswell Park Cancer Institute
Weiva SiehStanford University School of Medicine
Jenny LesterWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Alice S WhittemoreStanford University School of Medicine
Beth Y KarlanWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Aleksandra Gentry-MaharajUCL EGA Institute for Women's Health, University College London
Aleksandra Gentry-MaharajUCL EGA Institute for Women's Health, University College London
Usha MenonUCL EGA Institute for Women's Health, University College London
Usha MenonUCL EGA Institute for Women's Health, University College London
Douglas A LevineMemorial Sloan-Kettering Cancer Center
Douglas A LevineMemorial Sloan-Kettering Cancer Center
James D BrentonCancer Research UK Cambridge Institute, University of Cambridge
Ellen L GoodeMayo Clinic
Simon A GaytherWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Simon A GaytherCenter for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center
  • 1 - 40

Datasets